Why must Olympic athletes prove that they have asthma to be permitted to take inhaled β2-agonists?

被引：9
|
作者：
Weiler, JM [1 ]
机构：
[1] Univ Iowa, Iowa City, IA 52242 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2003年 / 111卷 / 01期
关键词：
D O I：
10.1067/mai.2003.113
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [21] Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
    Sousa-Pinto, B.
    Louis, R.
    Anto, J. M.
    Amaral, R.
    Sa-Sousa, A.
    Czarlewski, W.
    Brussino, L.
    Canonica, G. W.
    Chaves Loureiro, C.
    Cruz, A. A.
    Gemicioglu, B.
    Haahtela, T.
    Kupczyk, M.
    Kvedariene, V.
    Larenas-Linnemann, D. E.
    Okamoto, Y.
    Ollert, M.
    Pfaar, O.
    Pham-Thi, N.
    Puggioni, F.
    Regateiro, F. S.
    Romantowski, J.
    Sastre, J.
    Scichilone, N.
    Taborda-Barata, L.
    Ventura, M. T.
    Agache, I.
    Bedbrook, A.
    Becker, S.
    Bergmann, K. C.
    Bosnic-Anticevich, S.
    Bonini, M.
    Boulet, L. -P.
    Brusselle, G.
    Buhl, R.
    Cecchi, L.
    Charpin, D.
    de Blay, F.
    Del Giacco, S.
    Ivancevich, J. C.
    Jutel, M.
    Klimek, L.
    Kraxner, H.
    Kuna, P.
    Laune, D.
    Makela, M.
    Morais-Almeida, M.
    Nadif, R.
    Niedoszytko, M.
    Papadopoulos, N. G.
    PULMONOLOGY, 2025, 31 (01):
  • [22] Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review
    Amin, Suvina
    Soliman, Mena
    McIvor, Andrew
    Cave, Andrew
    Cabrera, Claudia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08): : 2556 - +
  • [23] Ambulatory use of inhaled β2-agonists for the treatment of asthma in Quebec -: A population-based utilization review
    Blais, R
    Grégoire, JP
    Rouleau, R
    Cartier, A
    Bouchard, J
    Boulet, LP
    CHEST, 2001, 119 (05) : 1316 - 1321
  • [24] Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting β2-agonists, and leukotriene modifiers in asthma
    Currie, Graeme P.
    Lee, Daniel K. C.
    Menzies, Daniel
    Lipworth, Brian J.
    CHEST, 2006, 130 (01) : 301 - 302
  • [25] Patients with asthma should use intermediate-acting inhaled β2-agonists only on an as-needed basis
    Drugs & Therapy Perspectives, 2006, 22 (1) : 12 - 13
  • [26] Transcriptome analysis in patients with asthma after inhaled combination therapy with long-acting β2-agonists and corticosteroids
    Liang, Ya-Ru
    Tzeng, I-Shiang
    Hsieh, Po-Chun
    Kuo, Chan-Yen
    Huang, Shiang-Yu
    Yang, Mei-Chen
    Wu, Yao-Kuang
    Lan, Chou-Chin
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2022, 19 (12): : 1770 - 1778
  • [27] Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma
    Buhl, Roland
    FitzGerald, J. Mark
    Busse, William W.
    RESPIRATORY MEDICINE, 2018, 143 : 82 - 90
  • [28] Long acting inhaled β2-agonists:: anti-inflammatory effects not evident during treatment of day to day asthma
    Durham, S
    EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (02) : 249 - 250
  • [29] Should combination therapy with inhaled corticosteroids and long-acting β2-agonists be prescribed as initial maintenance treatment for asthma?
    Lemière, C
    Becker, A
    Boulet, LP
    Bowie, D
    Cartier, A
    Cockroft, D
    Cowie, R
    Ernst, P
    Fitzgerald, M
    Sears, M
    Spier, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2002, 167 (09) : 1008 - 1009
  • [30] Prescription of fixed combinations of inhaled glucocorticosteroid and long-acting β2-agonists for childhood asthma in Denmark:: Are guidelines followed?
    Madsen, Hans K.
    Ranneries, Claudia
    Bisgaard, Hans
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S299 - S299
12345